Platinum-sensitive Small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-06-05
Clinical Trial Update: Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating lurbinectedin with durvalumab in pre-treated patients with extensive-stage small-cell lung cancer has been withdr…